تجاوز إلى المحتوى الرئيسي

Rectal versus vaginal bromocriptine mesylate suppositories in hyperprolactinemic patients : an active comparator trial .

ملخص البحث
The approached bromocriptine suppositories containing pluronic F127 were proven to be effective in lowering SP whether used vaginally or rectally as compared to oral treatment. Rectal approach has minimal side effects, it is more convenient for patients who don’t accept to manipulate the vagina especially virgins, others fail to use the drug during menstruation, or during the postabortive or postpartum periods and those patients who believe that the drug may affect their fertility by interfering with sexual relationship. Furthermore, it can be used by intolerant hyperprolactinemic males. Its use as an alternative non-oral approach should be considered during counseling of patients in those formerly mentioned situations.
مؤلف البحث
Atef M. Darwish, Ehsan Hafez, Ibraheem El-Gebali, Sahar B. Hassan, Mohammad E. Ali
مجلة البحث
Middle East Fertility Society Journal
مؤلف البحث
تصنيف البحث
1
عدد البحث
12,2:
سنة البحث
2007